title: [The use of extracorporeal blood purification for the treatment of cardiac rhythm disorders].
abstract: Hemosorption and plasmapheresis were used in 26 patients with episodes of atrial fibrillation and extrasystoles. A response lasting 4 +/- 0.9 months was registered in 80% of cases. Negative effects were absent.
authors.forename: A V
authors.initials: AV
authors.lastname: Nedostup
authors.forename: V V
authors.initials: VV
authors.lastname: Panasiuk
authors.forename: D A
authors.initials: DA
authors.lastname: Boldyrev
authors.forename: G V
authors.initials: GV
authors.lastname: Kalugina
authors.forename: M I
authors.initials: MI
authors.lastname: Ivanov
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Komiagin
mesh_terms: D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000097:blood / Q000628:therapy*; D005117:Cardiac Complexes, Premature / Q000097:blood / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005260:Female; D006464:Hemoperfusion / Q000009:adverse effects / Q000295:instrumentation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis / Q000009:adverse effects / Q000295:instrumentation
chemical_list: D000889:Anti-Arrhythmia Agents